Sequencing & GenomicsNext-Generation SequencingRUO

AVENIO Tumor Tissue Surveillance Kit V2

By Roche Diagnostics

Product TypeAssay Kit
TechnologyNext-Generation Sequencing
Regulatory StatusRUO

Key takeaways

AVENIO Tumor Tissue Surveillance Kit V2 is a product in the Sequencing & Genomics category, manufactured by Roche Diagnostics. Listed regulatory status: RUO (as reported by the manufacturer).

  • Platform: Next-Generation Sequencing
  • Applications: Oncology Markers
AVENIO Tumor Tissue Surveillance Kit V2 — Roche Diagnostics product image

Classification

Category
Sequencing & Genomics
Product Type
Assay Kit
Technology
Next-Generation Sequencing

Application

Application Area
Oncology Markers

Regulatory Status

RUO

Reported from manufacturer sources and not independently verified.

From the manufacturer

Quoted verbatim from the manufacturer’s published product page. IVDmap did not write or verify this text.

  • Designed for longitudinal monitoring of tumor burden, the AVENIO Tumor Tissue Surveillance Kit V2 is an NGS research use only assay that complements the AVENIO ctDNA by establishing a baseline from formalin-fixed paraffin-embedded (FFPE) tissue samples.
    Roche DiagnosticsProduct TypeManufacturer Page2026-10-28
  • Others AVENIO Tumor Tissue Surveillance Kit V2 RUO AVENIO Tumor Tissue Surveillance Kit V2 PID00000593 The AVENIO Tumor Tissue Analysis Kits V2 include the reagents needed to isolate DNA from formalin-fixed paraffin-embeded (FFPE) tissue, prepare sequencing libraries, and enrich selected regions of interest using one of three panel options:AVENIO Tumor Targeted Panel V2(17 genes)AVENIO Tumor…
    Roche DiagnosticsCategory L1Manufacturer Page2026-10-28

Review and references

Source

Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.

Published

2026-10-26

Updated

2026-10-31

Disclaimer

availability varies

Explore more